(REZ) iShares Residential - Ratings and Ratios
Residential, Healthcare, Self-Storage, Manufactured Homes
Dividends
| Dividend Yield | 1.63% |
| Yield on Cost 5y | 2.29% |
| Yield CAGR 5y | -3.96% |
| Payout Consistency | 91.7% |
| Payout Ratio | - |
| Risk via 5d forecast | |
|---|---|
| Volatility | 16.1% |
| Value at Risk 5%th | 27.1% |
| Relative Tail Risk | 2.42% |
| Reward TTM | |
|---|---|
| Sharpe Ratio | 0.14 |
| Alpha | -3.84 |
| CAGR/Max DD | 0.52 |
| Character TTM | |
|---|---|
| Hurst Exponent | 0.294 |
| Beta | 0.419 |
| Beta Downside | 0.489 |
| Drawdowns 3y | |
|---|---|
| Max DD | 19.40% |
| Mean DD | 6.13% |
| Median DD | 6.10% |
Description: REZ iShares Residential November 30, 2025
The iShares Residential and Multisector Real Estate ETF (REZ) commits at least 80% of its assets to the securities that compose its benchmark index, which tracks U.S. residential apartments, manufactured-home communities, healthcare facilities, and self-storage properties. The remaining allocation (up to 20%) may be placed in futures, options, swaps, cash, or cash equivalents, and the fund is classified as non-diversified under SEC rules.
Key market signals that drive REZ’s underlying sectors include: (1) the average cap rate for U.S. residential REITs was about 5.2% in Q3 2024, reflecting modest valuation pressure from rising borrowing costs; (2) self-storage vacancy rates have held near 4% nationally, supporting stable rent growth despite a slowdown in new construction; and (3) demographic trends-particularly the aging-baby-boomer cohort-continue to boost demand for senior-focused healthcare real estate, which historically outperforms during periods of low-interest-rate volatility.
For a deeper, data-rich analysis of REZ’s risk-adjusted performance and sector exposure, you might explore the ValueRay platform’s interactive dashboards.
What is the price of REZ shares?
Over the past week, the price has changed by +1.03%, over one month by -2.71%, over three months by +0.13% and over the past year by +6.88%.
Is REZ a buy, sell or hold?
What are the forecasts/targets for the REZ price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | - | - |
| Analysts Target Price | - | - |
| ValueRay Target Price | 87.4 | 4.9% |
REZ Fundamental Data Overview December 26, 2025
Beta = 1.0
Revenue TTM = 0.0 USD
EBIT TTM = 0.0 USD
EBITDA TTM = 0.0 USD
Long Term Debt = unknown (none)
Short Term Debt = unknown (none)
Debt = unknown
Net Debt = unknown
Enterprise Value = 779.2m USD (779.2m + (null Debt) - (null CCE))
Interest Coverage Ratio = unknown (Ebit TTM 0.0 / Interest Expense TTM 0.0)
FCF Yield = 0.0% (FCF TTM 0.0 / Enterprise Value 779.2m)
FCF Margin = unknown (Revenue TTM is 0 or missing)
Net Margin = unknown
Gross Margin = unknown ((Revenue TTM 0.0 - Cost of Revenue TTM 0.0) / Revenue TTM)
Tobins Q-Ratio = unknown (Enterprise Value 779.2m / Total Assets none)
Interest Expense / Debt = unknown (Interest Expense 0.0 / Debt none)
Taxrate = 21.0% (US default 21%)
NOPAT = 0.0 (EBIT 0.0 * (1 - 21.00%))
Current Ratio = unknown (Total Current Assets none / Total Current Liabilities none)
Debt / Equity = unknown (Debt none)
Debt / EBITDA = unknown (Net Debt none / EBITDA 0.0)
Debt / FCF = unknown (Net Debt none / FCF TTM 0.0)
Total Stockholder Equity = 0.0 (from calculated bookValueOfEquity)
RoA = unknown (Net Income 0.0 / Total Assets none)
RoE = unknown (Net Income TTM 0.0 / Total Stockholder Equity 0.0)
RoCE = unknown (EBIT 0.0 / Capital Employed )
RoIC = unknown (NOPAT 0.0, Invested Capital 0.0, EBIT 0.0)
WACC = 7.56% (E(779.2m)/V(779.2m) * Re(7.56%) + (debt-free company))
Discount Rate = 7.56% (= CAPM, Blume Beta Adj.) -> floored to rf + 0.7*ERP = 8.05%
Fair Price DCF = unknown (Cash Flow 0.0)
Additional Sources for REZ ETF
Tweets: X | Stocktwits
Fund Manager Positions: Dataroma | Stockcircle